StocksFin Logo
Sage Therapeutics, Inc. country of incorporation
|
|
Dr. Jeffrey Jonas
|
471 employees
NASDAQ | Healthcare | Biotechnology
Twist Bioscience Corporation country of incorporation
|
|
Ms. Emily Leproust
|
989 employees
NASDAQ | Healthcare | Diagnostics & Research
Q322 reported Nov 8, 2022 Reporting Period
$1.74M 20.8% vs. Q321 Revenues Q322
89.42% -1.6% vs. Q321 Gross Profit Margin
-1000% ! 0% vs. Q321 Net Profit Margin
-119.23M ! -73.2% vs. Q321 Free Cash Flow Q322
$-2.31 ! -4.5% vs. Q321 EPS Q322
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
Q123
Q123 reported Feb 7, 2023 Reporting Period
$54.24M 29.1% vs. Q122 Revenues Q123
45.72% 28.4% vs. Q122 Gross Profit Margin
-77.1% ! 28.9% vs. Q122 Net Profit Margin
-65.89M ! -41.2% vs. Q122 Free Cash Flow Q123
$-0.74 ! 18.7% vs. Q122 EPS Q123
-
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
Q123
Loading...
Loading...
Loading...
Loading...
Ratios
As of
Sep 30, 2022
Dec 31, 2022
Quick Ratio
14.17
5.76
Current Ratio
14.7
6.46
Cash Ratio
2
3.78
Price to Book
1.69
1.8
Price to Sales
100
24.78
Price to Earnings
-4.24
-8.03